Deep Track Capital, LP 89bio, Inc. Transaction History
Deep Track Capital, LP
- $2.86 Billion
- Q1 2025
A detailed history of Deep Track Capital, LP transactions in 89bio, Inc. stock. As of the latest transaction made, Deep Track Capital, LP holds 9,316,333 shares of ETNB stock, worth $97.1 Million. This represents 2.37% of its overall portfolio holdings.
Number of Shares
9,316,333
Previous 6,478,249
43.81%
Holding current value
$97.1 Million
Previous $49.7 Million
36.31%
% of portfolio
2.37%
Previous 2.19%
Shares
9 transactions
Others Institutions Holding ETNB
# of Institutions
208Shares Held
160MCall Options Held
366KPut Options Held
944K-
Janus Henderson Group PLC London, X020.5MShares$213 Million0.09% of portfolio
-
Ra Capital Management, L.P. Boston, MA19.9MShares$207 Million3.0% of portfolio
-
Suvretta Capital Management, LLC New York, NY14.3MShares$149 Million4.56% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.16MShares$74.6 Million0.0% of portfolio
-
Black Rock Inc. New York, NY7.02MShares$73.1 Million0.0% of portfolio
About 89bio, Inc.
- Ticker ETNB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,484,500
- Market Cap $484M
- Description
- 89bio, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapies for the treatment of liver and cardio-metabolic diseases. Its lead product candidate is pegozafermin, a glycoPEGylated analog of fibroblast growth factor 21 for the treatment of nonalcoholic steatohepatitis. The company also int...